Company
| Legal Name | Dynavax Technologies Corporation |
| Headquarters | Emeryville, United States |
| Website | https://dynavax.com |
TLR Immune Modulation The innate immune response is the front line of defense against viruses, bacteria and other potential pathogens. Toll-like Like Receptors (TLRs) are among the most important receptors used by all cell types to recognize and respond to the presence of these invaders. The human genome encodes 10 TLR that are similar in structure, but recognize different parts of viruses or bacteria. Four of these TLR recognize either DNA or RNA and are triggered by the genomes of microorganisms taken up by cells in specialized structures called endosomes.. Our Vision We are leaders in utilizing the innate immune system on behalf of patients to address unmet clinical needs. We are committed to a rigorous approach to drug development in the field of TLR biology and immune system modulation to attack the challenges of infectious and inflammatory diseases and cancer. Dynavax has partnered with AstraZeneca and GlaxoSmithKline to further the development of some candidates.
| Country | City | Job Ads |
|---|---|---|
| United States | Emeryville | 89 |
| Germany | Düsseldorf | 12 |
Loading map...
Legal Form: Corporation
Company Type: Public
Company Size: 51 - 250
Revenue: 25 - 100 billion (USD)
Job Ads found: 101
Job Ads per Month: 3.3
Hiring Locations: 2
| Date of first job ad | 26.11.2019, 21:30 |
| Date of last job ad | 09.11.2025, 04:49 |
| Date merged | 13.11.2025, 20:29 |
| Date created | 26.11.2019, 21:30 |